Two decades of innovation reveal mixed findings for quality, cost, and utilization—and unclear ways to resolve. The results are in on the impact of value-based payments (VBP) and once again, they're ...
Facing lower reimbursements and growing demands for price transparency, hospitals are demanding more evidence of differentiated value as they select medical device products. Moreover, hospitals are ...
Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare. For some time now, changes in the structure and dynamics of ...
WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences: WHAT: Webinar Targeted to Life Sciences Executives WHEN: October 11, 2022, 1:00 PM ET TOPIC: The Next-Generation Commercial Model – Questions ...
What’s the best way to improve commercial performance? For biopharma companies, according to a report from Accenture, the answer is investment and innovation. In a five-year study of 15 drugmakers, ...
The pharmaceutical industry is facing unprecedented disruption, necessitating a fundamental shift in how leaders perceive and respond to market dynamics. Traditional commercial models are no longer ...
The pharmaceutical industry is undergoing a commercial evolution. Traditional sales and marketing tactics — such as the classic in-person sales rep model — have declined, straining under the pressure ...
Meta Platforms Inc. is planning to release a commercial version of its artificial intelligence model designed for commercial use, according to a report today from the Financial Times. Meta released ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback